235 related articles for article (PubMed ID: 32573116)
1. Prediction of response to anti-vascular endothelial growth factor treatment in diabetic macular oedema using an optical coherence tomography-based machine learning method.
Cao J; You K; Jin K; Lou L; Wang Y; Chen M; Pan X; Shao J; Su Z; Wu J; Ye J
Acta Ophthalmol; 2021 Feb; 99(1):e19-e27. PubMed ID: 32573116
[TBL] [Abstract][Full Text] [Related]
2. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
[TBL] [Abstract][Full Text] [Related]
3. OCT-based deep learning algorithm for the evaluation of treatment indication with anti-vascular endothelial growth factor medications.
Prahs P; Radeck V; Mayer C; Cvetkov Y; Cvetkova N; Helbig H; Märker D
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):91-98. PubMed ID: 29127485
[TBL] [Abstract][Full Text] [Related]
4. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
Lee J; Moon BG; Cho AR; Yoon YH
Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
[TBL] [Abstract][Full Text] [Related]
5. Development of a 1-year risk-prediction nomogram for good functional response with anti-VEGF agents in naive diabetic macular oedema.
Gabrielle PH; Massin P; Arnould L; Couturier A; Bouché-Pillon J; Maupin E; Aho-Glele S; Bron AM; Kodjikian L; Creuzot-Garcher C
Acta Ophthalmol; 2020 Dec; 98(8):e975-e982. PubMed ID: 32268017
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning Can Predict Anti-VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema.
Gallardo M; Munk MR; Kurmann T; De Zanet S; Mosinska A; Karagoz IK; Zinkernagel MS; Wolf S; Sznitman R
Ophthalmol Retina; 2021 Jul; 5(7):604-624. PubMed ID: 33971352
[TBL] [Abstract][Full Text] [Related]
7. Vessel Density Changes on Optical Coherence Tomography Angiography after Vascular Endothelial Growth Factor Inhibitor Treatment for Diabetic Macular Edema.
Cheong KX; Lee SY; Ang M; Teo KYC
Turk J Ophthalmol; 2020 Dec; 50(6):343-350. PubMed ID: 33389934
[TBL] [Abstract][Full Text] [Related]
8. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
[TBL] [Abstract][Full Text] [Related]
9. Retinal Layers Changes in Patients with Diabetic Macular Edema Treated with Intravitreal Anti-VEGF Agents: Long-Term Outcomes of a Spectral-Domain OCT Study.
Chatziralli I; Kazantzis D; Theodossiadis G; Theodossiadis P; Sergentanis TN
Ophthalmic Res; 2021; 64(2):230-236. PubMed ID: 32564022
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy.
Eraslan S; Yıldırım Ö; Dursun Ö; Dinç E; Orekici Temel G
Turk J Ophthalmol; 2020 Jun; 50(3):163-168. PubMed ID: 32631004
[TBL] [Abstract][Full Text] [Related]
11. Aqueous Humor Cytokines and Long-Term Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema.
Felfeli T; Juncal VR; Hillier RJ; Mak MYK; Wong DT; Berger AR; Kohly RP; Kertes PJ; Eng KT; Boyd SR; Altomare F; Giavedoni LR; Muni RH
Am J Ophthalmol; 2019 Oct; 206():176-183. PubMed ID: 30959004
[TBL] [Abstract][Full Text] [Related]
12. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF RETINAL DEGENERATIVE CHANGES IN DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Boiko EV; Maltsev DS
Retina; 2018 Jul; 38(7):1324-1330. PubMed ID: 28492427
[TBL] [Abstract][Full Text] [Related]
13. Gender-related differences in patients treated with intravitreal anti-vascular endothelial growth factor medication for diabetic macular oedema.
Schiefelbein J; Müller M; Kern C; Herold T; Liegl R; Fasler K; Jeliazkova D; Priglinger S; Kortuem KU
Eur J Ophthalmol; 2020 Nov; 30(6):1410-1417. PubMed ID: 31937122
[TBL] [Abstract][Full Text] [Related]
14. Diabetic macular oedema treated with intravitreal anti-vascular endothelial growth factor - 2-4 years follow-up of visual acuity and retinal thickness in 566 patients following Danish national guidelines.
Hodzic-Hadzibegovic D; Sander BA; Monberg TJ; Larsen M; Lund-Andersen H
Acta Ophthalmol; 2018 May; 96(3):267-278. PubMed ID: 29240306
[TBL] [Abstract][Full Text] [Related]
15. Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy.
Huang CH; Yang CH; Hsieh YT; Yang CM; Ho TC; Lai TT
Sci Rep; 2021 Mar; 11(1):5103. PubMed ID: 33658601
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical outcomes of different components of diabetic macular edema on optical coherence tomography.
Hu Y; Wu Q; Liu B; Cao D; Dong X; Zhang L; Li T; Yang X; Yu H
Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2613-2621. PubMed ID: 31529324
[TBL] [Abstract][Full Text] [Related]
17. Machine learning and optical coherence tomography-derived radiomics analysis to predict persistent diabetic macular edema in patients undergoing anti-VEGF intravitreal therapy.
Meng Z; Chen Y; Li H; Zhang Y; Yao X; Meng Y; Shi W; Liang Y; Hu Y; Liu D; Xie M; Yan B; Luo J
J Transl Med; 2024 Apr; 22(1):358. PubMed ID: 38627718
[TBL] [Abstract][Full Text] [Related]
18. OPTICAL COHERENCE TOMOGRAPHY BASELINE PREDICTORS FOR INITIAL BEST-CORRECTED VISUAL ACUITY RESPONSE TO INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN EYES WITH DIABETIC MACULAR EDEMA: The CHARTRES Study.
Santos AR; Costa MÂ; Schwartz C; Alves D; Figueira J; Silva R; Cunha-Vaz JG
Retina; 2018 Jun; 38(6):1110-1119. PubMed ID: 28613220
[TBL] [Abstract][Full Text] [Related]
19. The impact of ganglion cell layer cysts in diabetic macular oedema treated with anti-vascular endothelial growth factor.
Ceklic L; Huf W; Ebneter A; Wolf S; Zinkernagel MS; Munk MR
Acta Ophthalmol; 2019 Dec; 97(8):e1041-e1047. PubMed ID: 31099498
[TBL] [Abstract][Full Text] [Related]
20. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
